Ironwood Pharmaceuticals (IRWD) Work In Process (2016 - 2019)

Ironwood Pharmaceuticals (IRWD) reported Work In Process of $392000.0 for Q4 2019, down 44.55% sequentially from $707000.0 in Q3 2019.

Ironwood Pharmaceuticals (IRWD) Work In Process (2016 - 2019) Analysis & Trends

Ironwood Pharmaceuticals (IRWD) has 2 years of Work In Process data on file, last reported at $392000.0 in Q4 2019.

For the quarter ending Q4 2019, Work In Process changed N/A year-over-year to $392000.0; the trailing twelve-month figure through Dec 2019 stood at $392000.0 (changed N/A YoY), and the FY2019 full-year result was $392000.0, changed N/A from the prior year.
Work In Process retreated to $392000.0 in Q4 2019, from $707000.0 in the prior quarter.
In the past five years, Work In Process ranged from a high of $707000.0 in Q3 2019 to a low of $71000.0 in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Ironwood Pharmaceuticals	619.48 Mn	399.01 Mn	-

Download Data